Related Experiment Video
Updated: Jan 19, 2026

07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
19.5K
Parotid Gland Tumours: Our Experience
Nirali Chauhan1, Jinesh Atulkumar Shah1
1Department of Otorhinolaryngology and Head and Neck Surgery, Smt. B. K. Shah Medical Institute and Research Centre, Piparia, Waghodia, Vadodara, Gujarat 391760 India.
Summary
Fine needle aspiration cytology (FNAC) is a reliable initial diagnostic tool for parotid tumors, differentiating benign from malignant conditions. Its high accuracy aids in planning effective surgical management for head and neck neoplasms.
Area of Science:
- Oncology
- Head and Neck Surgery
- Diagnostic Cytopathology
Background:
- Salivary gland tumors represent 3-10% of head and neck neoplasms.
- Parotid gland tumors are the most frequent, accounting for 62% of cases.
- Clinical presentation of benign and malignant salivary tumors often overlap, necessitating accurate diagnosis.
Purpose of the Study:
- To retrospectively analyze parotid tumors.
- To determine demographic distribution and evaluate cytological and histopathological findings.
- To correlate pre-operative fine needle aspiration cytology (FNAC) with post-operative histopathology.
Main Methods:
- Retrospective observational study of 31 patients with parotid swelling.
- Correlation of pre-operative FNAC findings with post-operative histopathological results.
- Surgical management decisions based on the diagnosed nature of the tumor.
Main Results:
- High concordance between FNAC and histopathology (27 out of 31 cases).
- FNAC sensitivity of 81.81%, specificity of 94.73%, and accuracy of 90% for parotid tumors.
- FNAC proved effective in differentiating benign from malignant parotid neoplasms.
Conclusions:
- FNAC is a valuable, minimally invasive, and cost-effective first-line investigation for parotid tumors.
- Accurate pre-operative diagnosis via FNAC facilitates appropriate surgical planning.
- FNAC significantly aids in distinguishing benign from malignant parotid gland tumors.

